ArticleCancers2025

Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Franz Zehentmayr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.